0001181431-11-026370.txt : 20110502
0001181431-11-026370.hdr.sgml : 20110502
20110502173310
ACCESSION NUMBER: 0001181431-11-026370
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110428
FILED AS OF DATE: 20110502
DATE AS OF CHANGE: 20110502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HA NGOC TUAN
CENTRAL INDEX KEY: 0001241221
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34655
FILM NUMBER: 11802146
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001325879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 SIDNEY STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6172995000
MAIL ADDRESS:
STREET 1: 75 SIDNEY STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
rrd309869.xml
HA-NGOC FORM 4
X0303
4
2011-04-28
0
0001325879
AVEO PHARMACEUTICALS INC
AVEO
0001241221
HA NGOC TUAN
C/O AVEO PHARMACEUTICALS, INC.
75 SIDNEY STREET
CAMBRIDGE
MA
02139
1
1
0
0
Chief Executive Officer
Common Stock
2011-04-28
4
M
0
3300
2.00
A
87704
D
Common Stock
2011-04-28
4
S
0
3300
16.0385
D
84404
D
Common Stock
170329
I
Held by GRAT
Stock Option (right-to-buy)
2.00
2011-04-28
4
M
0
3300
0
D
2016-02-09
Common Stock
3300
84200
D
The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2011.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.11, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein.
This option was fully vested as of January 1, 2010.
/s/ Joseph D. Vittiglio, attorney-in-fact
2011-05-02